Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2025-12-25 @ 1:32 AM
NCT ID:
NCT06419894
Eligibility Criteria:
Inclusion criteria:
* Suspected obstructive coronary artery disease
* No documented prior history of coronary artery disease
* Clinical referral for invasive coronary angiography according to the referring clinician's decision
* Competent adult (age ≥18 years)
* Signed informed consent
Exclusion criteria:
* Acute coronary syndrome
* History of coronary revascularization (percutaneous coronary intervention or coronary artery bypass grafting surgery)
* History of coronary artery disease or acute coronary syndrome (myocardial infarction, unstable angina)
* Use of sildenafil or dipyridamole that cannot be terminated
* Pregnancy or lactation
* Allergic reaction to iodized contrast
* Concurrent or prior (within last 30 days) participation in other research studies using interventional drugs
* Extensive comorbidities (i.e. cancer, other severe chronic diseases)
* Contraindication for cardiac magnetic resonance with gadolinium-based contrast agent (including severe claustrophobia, magnetic resonance unsafe implants/devices or MR conditional devices not suitable for 3T scanner, severe renal failure with estimated glomerular filtration rate\<30 mL/min/1,73 m2, known hypersensitivity for gadolinium-based contrast agent)
* Contraindications for adenosine usage (including hypersensitivity to adenosine/dipyridamole/regadenoson, second or third degree atrio-ventricular block, sick sinus syndrome, sinus bradycardia (heart rate \<40 bpm), long QT syndrome, severe hypertension (\> 220/120 mmHg), systolic blood pressure \<90mmHg, concomitant use of dipyridamole, severe asthma or severe chronic obstructive pulmonary disease)
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06419894
Study Brief:
Protocol Section:
NCT06419894